ライフサイエンスコーパス: screening for

1 We received data on disease screenings for 105,541 individuals who received a domest

2 Annual computed tomography (CT) screening for 3 years versus no screening.

3 pecific processes by a comprehensive suspect screening for 723,288 possible transformation products.

4 the rapid electrochemical reaction condition screening for a radical-radical cross-coupling reaction

5 we initiated a chemical genetics approach by screening for a stage-specific inhibitor of morphologica

6 ake an impact in drug discovery, drug safety screening for a variety of compounds and targets, and in

7 SPSTF concludes with moderate certainty that screening for AAA in men aged 65 to 75 years who have ev

8 SPSTF concludes with moderate certainty that screening for AAA in men aged 65 to 75 years who have ne

9 es with moderate certainty that the harms of screening for AAA in women aged 65 to 75 years who have

10 ation) The USPSTF recommends against routine screening for AAA with ultrasonography in women who have

11 Population screening for abdominal aortic aneurysm (AAA) has commen

12 We assessed the effectiveness of screening for active tuberculosis before entry to the UK

13 Noninvasive screening for advanced alcohol-related fibrosis is a cos

14 In screening for AF among participants with stroke risk fac

15 Screening for AF has gained substantial attention in rec

16 nabled a variety of approaches to facilitate screening for AF using both medical-prescribed devices a

17 Force reviewed the benefits and harms of ECG screening for AFib in adults aged 65 years or older and

18 lia and New Zealand, which found that active screening for AFib in patients older than 65 years may b

19 diologists discuss the risks and benefits of screening for AFib, if and when they would recommend scr

20 el of alcohol use that should prompt further screening for alcohol-related problems following RYGB is

21 Tanzania has implemented nationwide malaria screening for all pregnant women within the antenatal ca

22 Only 1 strong recommendation was formulated: screening for Alzheimer-type dementia starting at age 40

23 In Burkina Faso, monthly screening for AM of children <2 years of age is conducte

24 Finally, screening for and management of anemia should continue i

25 ent decisions, the present evidence supports screening for and targeting of modifiable risk factors f

26 Methods to reduce unnecessary screening for and treatment of asymptomatic bacteriuria

27 SPSTF concludes with moderate certainty that screening for and treatment of asymptomatic bacteriuria

28 SPSTF concludes with moderate certainty that screening for and treatment of asymptomatic bacteriuria

29 ed the evidence on the benefits and harms of screening for and treatment of elevated blood lead level

30 Screening for, and treatment of, latent Mycobacterium tu

31 nt monogenic diseases, complementing current screening for aneuploidies or carrier screening for rece

32 t of a nephritic syndrome with low C3 level, screening for anti-factor B antibodies might help guide

33 yryl)pyrazoles 2a-l, thus allowing for their screening for antiproliferative activity in the androgen

34 presentatives, developed a recommendation on screening for anxiety in adolescent and adult women to i

35 Screening for anxiety in adolescent and adult women: a r

36 The WPSI recommends screening for anxiety in women and adolescent girls aged

37 ce on the overall effectiveness and harms of screening for anxiety is insufficient.

38 Regarding the F1 offspring, screening for anxiety-related behaviours using the eleva

39 luated the overall effectiveness or harms of screening for anxiety.

40 and individuals, to maximize the benefits of screening for any population.

41 us to perform efficient and high-throughput screenings for ASOs.

42 ents suitable to undergo in-depth autoimmune screening for astrocytic antibodies.

43 SPSTF concludes with moderate certainty that screening for asymptomatic bacterial vaginosis in pregna

44 Screening for asymptomatic bacteriuria can identify pati

45 The USPSTF recommends against screening for asymptomatic bacteriuria in nonpregnant ad

46 Screening for asymptomatic complications and close surve

47 fraction of patients with H-ABC; therefore, screening for auditory function should be done on patien

48 ted SCAD pathogenesis is noninflammatory and screening for autoimmune diseases based on SCAD alone is

49 its 2004 "D" recommendation against routine screening for average-risk patients.

50 2DE screening for BA-CCM may provide pertinent clinical info

51 assess the balance of benefits and harms of screening for bacterial vaginosis in pregnant persons at

52 The USPSTF recommends against screening for bacterial vaginosis in pregnant persons no

53 EEG has the potential to improve diagnostic screening for BECTS and predict clinical outcomes.

54 Screening for BKPyV viremia after HCT identifies asympto

55 The introduction of molecular screening for Blastocystis sp. at our stool bank identif

56 for individual gene knockout and genome-wide screening for both the human and mouse genomes.

57 tors (antenatal care, full immunisation, and screening for breast and cervical cancers) and four trea

58 80 controls), of whom 69.85% were women, for screening for breast cancer (k=35; 296 699 individuals w

59 ed treatment/genetic risks and the impact of screening for breast cancer in the St Jude Lifetime Coho

60 Screening for breast cancer reduces breast cancer-relate

61 ificantly less likely to undergo mammography screening for breast cancer than women without VI.

62 aged 50 to 74 years, clinicians should offer screening for breast cancer with biennial mammography.

63 years or less, clinicians should discontinue screening for breast cancer.

64 g-enhancing mutations into GFP templates and screening for brightness and expression rate in human ce

65 tabarcoding have potential for indicative BW screening for BW compliance monitoring, further research

66 l experience, the consortium determined that screening for C9orf72 mutation should be performed in al

67 a precursor to esophageal adenocarinoma, and screening for cancer risk focuses upon histologic assess

68 Our findings will enable screening for candidate molecular mechanisms from readil

69 the diagnosis of cardiovascular disease(1), screening for cardiotoxicity(2) and decisions regarding

70 Thus, screening for cardiovascular disease and risk stratifica

71 In newborns undergoing targeted screening for cCMV, saliva real-time PCR is highly sensi

72 ncy virus (HIV), followed by a comprehensive screening for cell-modulatory activity by High-Content S

73 ith high-throughput microfluidic single-cell screening for cells with improved protein secretion.

74 Screening for cellular rejection in the absence of SC-AB

75 influence risk stratification of women when screening for cervical cancer and inform HPV vaccination

76 lth care coverage, she had had only sporadic screening for cervical cancer over the past 15 years.

77 Newborn screening for CF has enabled earlier diagnosis, nutritio

78 alized, automated electronic alerts increase screening for CHB, but more comprehensive measures are n

79 Through screening for chemical suppressors of sspo mutant phenot

80 uggest that the benefits of population-based screening for CKD are uncertain; that there is potential

81 in a primary care setting and in eligibility screening for clinical trials.

82 Validation included univariable screening for clinical variables that could improve perf

83 ng, and the balance of benefits and harms of screening for cognitive impairment cannot be determined.

84 here is no empirical evidence, however, that screening for cognitive impairment improves patient or c

85 assess the balance of benefits and harms of screening for cognitive impairment in older adults.

86 Screening for cognitive impairment in older adults: US P

87 CT) (n = 4005) examined the direct effect of screening for cognitive impairment on patient outcomes,

88 ostapproval clinical experience with mt-sDNA screening for colorectal cancer (CRC) and compare result

89 Screening for colorectal cancer (CRC) is effective in th

90 e and cost effectiveness of population-based screening for colorectal cancer (CRC) is missing.

91 E STATEMENT 3: Clinicians should discontinue screening for colorectal cancer in average-risk adults o

92 ons against hepatitis B virus infection, and screening for colorectal cancer.

93 Screening for compounds that perturb CPAP-tubulin intera

94 ermore, based on a polymerase chain reaction screening for core BL genes, 93% of children with BL-BGC

95 , including education of staff and patients, screening for COVID-19 and separation of infected or sym

96 Traditional screening for COVID-19 typically includes survey questio

97 Despite being approved only for screening for CRC, numerous studies in the past have ill

98 Our crosslinkomics approach was tested by screening for crosslinks in formaldehyde- and chlorambuc

99 Screening for cryptococcal antigen combined with a short

100 Poor vision (41.9%), screening for diabetic and hypertensive retinopathy (13.

101 ut evolutionary synthesis of genes and their screening for dictated functionalities, we introduce the

102 probe could include high-throughput optical screening for discovering new classes of channels, or fi

103 , we established a proof of applicability of screening for distinct G proteins on dopamine receptor D

104 Screening for drug and alcohol use should become part of

105 identification of intraligand NOEs in ligand screening for drug discovery.

106 al and pathological processes and facilitate screening for drug or gene candidates that affect uptake

107 Current guidelines around preclinical screening for drug-induced arrhythmias require the measu

108 kylating agents, should inform breast cancer screening for early detection.

109 eloped a fever >=37.5oC necessitating urgent screening for Ebola virus and a small number developed p

110 fever >=37.5 degrees C, necessitating urgent screening for Ebola virus, and a small number developed

111 Screening for either one of the mismatch profiles result

112 nd that the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic

113 assess the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic

114 assess the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic

115 assess the balance of benefits and harms of screening for elevated blood lead levels in asymptomatic

116 Screening for eligibility, data extraction, and quality

117 Resistance genotypes were performed during screening for enrollment into a trial of third-line ART

118 Resistance genotypes were performed during screening for enrollment into a trial of third-line ART

119 Some crystals are suitable for screening for entry-blocking inhibitors.

120 Screening for ESBL-PE carriage before colorectal surgery

121 unnecessary esophagogastroduodenoscopy (EGD) screening for esophageal varices needing treatment (EVNT

122 maximum caliber methods in automated disease screening, for example in the identification of behavior

123 of diagnostic testing, as well as increased screening for extragenital infections among men who have

124 RNA-sequencing screening for factors induced by activation of Ocn-Cre(+

125 Advice by mail, screening for fall risk, and a targeted exercise or mult

126 ated the effect of advice sent by mail, risk screening for falls, and targeted interventions (multifa

127 Testing for elevated Lp(a) during cascade screening for FH is effective in identifying relatives w

128 Expression screening for Fli-1 inhibitors identified lumefantrine,

129 Screening for function against MRSA (USA300) revealed se

130 es were highlighted, including improving the screening for GBS colonization in pregnant women, offeri

131 netic pathways that specify this polarity by screening for gene inactivations and mutations that disr

132 Routine screening for genetic variants causing thoracic aortic d

133 Population screening for glaucoma (POAG and PACG combined) is likel

134 SPSTF concludes with moderate certainty that screening for HBV infection in adolescents and adults at

135 The USPSTF recommends screening for HBV infection in adolescents and adults at

136 No study directly evaluated the effects of screening for HBV infection vs no screening on clinical

137 l considerations include recommendations for screening for HCC in persons at risk, treatment with ant

138 Universal screening for HCV among pregnant women in the United Sta

139 n, improve access to treatment, and increase screening for HCV infection by considering six scenarios

140 The USPSTF recommends screening for HCV infection in adults aged 18 to 79 year

141 SPSTF concludes with moderate certainty that screening for HCV infection in adults aged 18 to 79 year

142 PWID harm reduction services, and extensive screening for HCV with concomitant treatment for all are

143 performed a population-based and systematic screening for HCV-RNA among MSM from the SHCS.

144 vices Task Force Recommendation Statement on screening for hepatitis B infection in pregnant women su

145 Screening for hepatitis B virus (HBV) infection during p

146 Screening for hepatitis C virus infection in adolescents

147 With improved screening for hepatobiliary malignancies in patients wit

148 Screening for hepatopulmonary syndrome (HPS) using pulse

149 SPSTF concludes that the evidence to support screening for high blood pressure in children and adoles

150 assess the balance of benefits and harms of screening for high blood pressure in children and adoles

151 ion in pregnant persons, the yield of repeat screening for HIV at different intervals during pregnanc

152 To determine if women screening for HIV clinical trials enrolled at lower rate

153 regnant adolescents and adults, the yield of screening for HIV infection at different intervals, the

154 with high certainty that the net benefit of screening for HIV infection in adolescents, adults, and

155 (A recommendation) The USPSTF recommends screening for HIV infection in all pregnant persons, inc

156 ed the evidence on the benefits and harms of screening for HIV infection in nonpregnant adolescents a

157 transmission of HIV infection) and harms of screening for HIV infection in pregnant persons, the yie

158 urine-based tuberculosis screening to sputum screening for hospitalised patients with HIV.

159 he World Health Organization recommends CrAg screening for human immunodeficiency virus-positive pers

160 tudy to show the value of genetic diagnostic screening for hypouricemia in the clinical setting.

161 ectiveness of magnetic resonance angiography screening for IA in patients with coarctation of the aor

162 luidics system that combines high-throughput screening for IgG activity, using fluorescence-based in-

163 chine learning and text mining to reduce the screening for inclusion workload and improve accuracy.

164 ) recommends a domestic medical examination (screening for infectious and noninfectious diseases/cond

165 or Health Protection in Hong Kong introduced screening for influenza C virus (ICV) as part of its rou

166 ication to high-throughput screening enabled screening for inhibitors of OGT, leading to a novel inhi

167 ibility of fast and accurate anti-viral drug screening for inhibitors of SARS-CoV-2 and provides pote

168 hat can be easily applied to high-throughput screening for inhibitors of these enzymes have been chal

169 The frequency and patterns of screening for intracranial aneurysms have not been defin

170 Conclusion Screening for intracranial aneurysms with MR angiography

171 DESIGN, SETTING, AND PARTICIPANTS: Screening for islet autoantibodies was offered to childr

172 ts for anaemia and the costs associated with screening for it, the condition is often undetected.

173 Conclusion Screening for large-vessel occlusion with CT angiography

174 ssociated with GPCRs through the coupling of screening for Lasso of long extended-connectivity finger

175 ization of HIV-1 latency and high-throughput screening for latency-reversing agents (LRAs).

176 In endemic areas, screening for latent or subclinical histoplasmosis shoul

177 By contrast, screening for latent tuberculosis before immune checkpoi

178 This is beneficial when screening for ligands targeting orphan GPCRs since the s

179 n no longer leverages the common approach of screening for low intrinsic clearance in vitro to target

180 patients, and the test appears reliable for screening for lower extremity deep venous thrombosis at

181 Stopping reflex CRC screening for LS after age 80 years may be reasonable be

182 Effort to raise public awareness screening for lung cancer has been ongoing.

183 The effectiveness of screening for macrosomia is not well established.

184 However, screening for many dominant monogenic disorders associat

185 Screening for marijuana use is encouraged, especially in

186 he potential of highly-mulitplexed genotypic screening for measuring resistance-association of mutati

187 Services Programs (SSPs) could benefit from screening for mental illness among young PWID and strong

188 ate methodology for fast, enzyme-multiplexed screening for metabolite-protein adducts was developed.

189 lexed strand and is therefore attractive for screening for metal-mediated base pairing events.

190 Screening for microbiome modulators requires availabilit

191 new yeast models are powerful platforms for screening for modulators of FUS-CHOP and EWS-FLI phase s

192 ly from tissue images may enable image-based screening for molecular biomarkers with spatial variatio

193 ic frustration analysis provides a route for screening for more specific compounds for drug discovery

194 Screening for mutations that block LEN-induced megakaryo

195 uding the following recommendations: Routine screening for NAFLD in high-risk groups is not advised b

196 n establishing cost-effective strategies for screening for NASH, advanced fibrosis, and cirrhosis, in

197 tein-Barr virus (EBV) have been proposed for screening for nasopharyngeal carcinoma (NPC).

198 national guidelines recommend the systematic screening for Neisseria gonorrhoeae (NG) and Chlamydia t

199 d aptasensors provide efficient and rapid DA screening for neuron-mediated genetic diseases such as P

200 erformed large scale structure-based virtual screening for new ligand chemotypes using recently solve

201 d as an indicator of cellular noise and drug screening for noise control.

202 Based on a decision analysis, screening for noncardia gastric adenocarcinoma might be

203 tial alternative for massive high-throughput screening for NSCLC in clinical specimens.

204 ardiovascular disease and stroke prevention, screening for obesity, and evaluation for secondary caus

205 reening examinations of SIVH should consider screening for obesity-as per the CDC's Guidelines for th

206 ce of biofluid may impact study outcome when screening for obesity-related biomarkers and we identify

207 with chronic stable hypercapnic COPD undergo screening for obstructive sleep apnea before initiation

208 egree family members should undergo clinical screening for occult cardiac disease, but the diagnostic

209 rs, previously trained to undertake trachoma screening for one month, performed eye examination.

210 Baseline CD4 counts and screening for opportunistic infections, such as tubercul

211 TF found inadequate evidence on the harms of screening for or treatment of elevated blood lead levels

212 US clinicians can consider screening for other NCDs at the domestic screening exami

213 neoplastic progression and may also lead to screening for other relevant associated cancers.

214 Screening for P. falciparum infections, using both micro

215 ytic Markov models for separate and combined screening for PACG and primary open angle glaucoma (POAG

216 ce Update is to describe the indications for screening for pancreas cancer in high-risk individuals.

217 idence that the magnitude of the benefits of screening for pancreatic cancer in asymptomatic adults c

218 The USPSTF recommends against screening for pancreatic cancer in asymptomatic adults.

219 of DDR germline variants could guide cancer screening for patients and their families and serve as p

220 Hospitals may consider admission screening for patients known to have CPE-colonized house

221 mation for risk-adapted starting ages of CRC screening for patients with diabetes, who are at higher

222 Screening for PDAC is not a standard practice among the

223 Prior convention held that screening for PDAC would not be beneficial; however, a d

224 HIV screening for persons aged 13-64 years (excluding person

225 the results of the suspect and non-targeted screening for pesticides can be made quantitative with t

226 Our findings suggest that screening for PF in relatives might be warranted.

227 dence is unclear regarding the usefulness of screening for pineal TRb and, if useful, the age up to w

228 e or greatly reduce the need of experimental screening for polymorphism and ensure that the flanking

229 stinjury to measure: presence of daily pain; screening for post-traumatic stress disorder (PTSD); new

230 ult survivors of critical illness related to screening for postdischarge impairments.

231 The probe design was also applied in screening for potential NTH1 inhibitors, leading to the

232 ng driver mutation detection and therapeutic screening for pregnancy/postpartum breast cancers.

233 We assessed the cost-effectiveness of HCV screening for pregnant women in the United States.

234 MRI screening for prostate cancer has the potential to be an

235 ebate has taken place about population-based screening for prostate cancer.

236 ssay now enables straightforward large-scale screening for PSD inhibitors against pathogenic fungi, a

237 ased fluorescent readouts in high-throughput screening for PSD inhibitors.

238 king it readily adaptable to high-throughput screening for PSD inhibitors.

239 enomic sequencing can potentially expand the screening for rare hereditary disorders, but many questi

240 for screening, and a new analysis shows that screening for RCC could potentially be cost-effective.

241 urrent screening for aneuploidies or carrier screening for recessive disorders.

242 retinoblastoma tumors are now detected with screening for retinal tumors in at-risk neonates (those

243 to improve outcomes of secondary prevention screening for retinoblastoma.

244 The NPV of MRSA nares screening for ruling out MRSA infection was 96.5%.

245 All donors underwent screening for SARS-CoV-2 prior to LT.

246 ial to enable rapid, low-cost, point-of-care screening for SARS-CoV-2.

247 r rapid neutralization testing and antiviral screening for SARS-CoV-2.

248 sis, particularly in countries where newborn screening for SCID is not universally available and dela

249 In conclusion, in KT, screening for SCR more than once during the first year i

250 nstrate the utility of cell-based phenotypic screening for Select Agent drug discovery and warrant th

251 Screening for serum PCT levels in patients with periodon

252 Patients were identified through newborn screening for severe combined immunodeficiency using the

253 or serious gonococcal infections and perform screening for sexually transmitted diseases (STDs) per t

254 is splicing pattern, we performed a pan-TCGA screening for SF3B1-specific aberrant acceptor usage.

255 Risk-stratification screening for SGA has been proposed in high-income count

256 e tests are reliable and accurate in newborn screening for sickle cell disease.

257 ollected 6-month outcomes as measured by the Screening for Somatoform Symptoms Conversion Disorder su

258 Consequently, screening for some cancers may have minimal impact on mo

259 aphy studies of sleep health and potentially screening for some sleep disorders.

260 , 87%, 78%, 57%, and 64% reported consistent screening for STIs by blood sample, urine sample or uret

261 n and purification, and in vivo microcrystal screening for structural studies.

262 Furthermore, screening for suspects in LC-HRMS data resulted in the d

263 nitoring of growth and nutrition, as well as screening for symptoms of EoE, allergy and mindfulness r

264 e validate our optimized AsCas12a toolkit by screening for synthetic lethalities in OVCAR8 and A375 c

265 hild transmission of syphilis, such as early screening for syphilis in pregnant women, universal cove

266 Screening for syphilis is performed using either a nontr

267 iderations should be taken into account when screening for syphilis using the traditional or reverse

268 library containing nearly 4000 fragments and screening for target-specific binders within days.

269 Screening for targets of MAGE-A11 revealed that it ubiqu

270 y tau pathology in AD, are very suitable for screening for tau inclusion inhibitors.

271 Screening for TB at the point of HIV diagnosis with a hi

272 umour biopsy or consented to a new biopsy at screening for the analysis of FGFR1-3 mRNA expression.

273 Here we used (19)F NMR fragment screening for the discovery of novel, ligand-efficient S

274 luable tools in accelerated first-principles screening for the discovery of the next generation of fu

275 Screening for the MEPE LoF mutations before adulthood co

276 erformed real-time polymerase chain reaction screening for the new variant.

277 combination of deep sequencing and PCR-based screening for the presence of 22 different mitochondrial

278 way to developing a new and simple method of screening for the risk of chronic kidney disease in adul

279 nance of neuromuscular health and facilitate screening for therapeutic targets.

280 relatives, supporting the use of systematic screening for these conditions.

281 onal risk factors elevates the importance of screening for these risk factors, improving the effectiv

282 e age 50, there are recommendations to start screening for this group earlier.

283 ty of America (IDSA) guidelines recommending screening for this group.

284 Careful screening for this variant may be required in MSM, given

285 driving efforts to more stringent diagnostic screening for thrombotic complications and to the early

286 should be a greater priority for bioactivity screening for thyroid axis disruptors.

287 ntive Services Task Force recommends against screening for thyroid cancer in the general, asymptomati

288 signs, and high-throughput biosensor-enabled screening for training diverse machine learning algorith

289 n Malawi and South Africa (Rapid urine-based Screening for Tuberculosis to reduce AIDS Related Mortal

290 tudy was nested within the rapid urine-based screening for tuberculosis to reduce AIDS-related mortal

291 the two-country randomised Rapid Urine-based Screening for Tuberculosis to Reduce AIDS-related Mortal

292 Public health screening for type 1 diabetes in its presymptomatic stag

293 STF concludes that the benefits and harms of screening for unhealthy drug use are uncertain and that

294 assess the balance of benefits and harms of screening for unhealthy drug use in adolescents.

295 Screening for unhealthy drug use: US Preventive Services

296 Screening for variants of cytotoxity genes was systemati

297 Conclusion Risk-based screening for women 40-49 years old includes few women i

298 HPV vaccination and cervical cancer screening for women living with HIV are especially impor

299 o of the biggest barriers to cervical cancer screening for women.

300 ody, this approach can facilitate laboratory screening for ZIKV infection, especially in regions wher